Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 3, November

Concanavalin A, from an Old Protein to Novel Candidate Anti-Neoplastic Drug

Volume:3   Issue: 3
Pp: 123-128
Chun-Yang Li, Huai-Long Xu, Bo Liu and Jin-Ku Bao
DOI: 10.2174/1874467211003030123
Published on: 01 March, 2012

The Enigmatic Drug Binding Site for Sodium Channel Inhibitors

Volume:3   Issue: 3
Pp: 129-144
Arpad Mike and Peter Lukacs
DOI: 10.2174/1874467211003030129
Published on: 01 March, 2012

Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

Volume:3   Issue: 3
Pp: 145-152
Benjamin Ngo, Christopher P. Farrell, Maura Barr, Kevin Wolov, Robert Bailey, James M. Mullin and James J. Thornton
DOI: 10.2174/1874467211003030145
Published on: 01 March, 2012

Biological Activities of Natural and Engineered Cyclotides, a Novel Molecular Scaffold for Peptide-Based Therapeutics

Volume:3   Issue: 3
Pp: 153-163
Angie E. Garcia and Julio A. Camarero
DOI: 10.2174/1874467211003030153
Published on: 01 March, 2012

Drug Screening for Huntingtons Disease and other Neurodegenerative Disorders

Volume:3   Issue: 3
Pp: 164-173
Hemant Varma
DOI: 10.2174/1874467211003030164
Published on: 01 March, 2012